Johnson & Johnson Spray Approved to Treat Suicidal People
Johnson & Johnson first aid products are arranged for a photograph in Tiskilwa, Illinois, U.S., on Thursday, July 2, 2015. Johnson & Johnson is expected to report quarterly earnings on July 14, 2015. Photographer: Daniel Acker/Bloomberg

Johnson & Johnson Spray Approved to Treat Suicidal People

(Bloomberg) -- Johnson & Johnson’s Spravato has been approved as the first antidepressant for actively suicidal people, as doctors are becoming increasingly concerned about Covid-19’s effect on the...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.